Palonosetron Hydrochloride
Palonosetron Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Palonosetron Hydrochloride; Generic name: PALONOSETRON HYDROCHLORIDE; Manufacturer: Mylan Institutional LLC.
| Brand name | Palonosetron Hydrochloride |
|---|---|
| Generic name | PALONOSETRON HYDROCHLORIDE |
| Manufacturer | Mylan Institutional LLC |
| Used for | 1 INDICATIONS AND USAGE Palonosetron hydrochloride injection is indicated in adults for prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). • acute nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC). • postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. Efficacy beyond 24 hours has not been demonstrated. As with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and vomiting mu |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Chemotherapy-Induced Nausea and Vomiting ( 2.1 ) Age Dose Note different dosing units in pediatrics Infusion Time Adults 0.25 mg as a single dose Infuse over 30 second s beginning approximately 30 minutes before the start of chemotherapy Pediatrics (1 month to less than 17 years) 20 micrograms per kilogram (maximum 1.5 mg) as a single dose Infuse over 15 minutes beginning approximately 30 minutes before the start of chemotherapy Postoperative Nausea and Vomiting ( 2 |
| Active ingredient(s) | PALONOSETRON HYDROCHLORIDE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a781796-bb74-4c5f-8d26-9ce520b818f7 |